Novus Biologicals products are now on bio-techne.com

KIR2DL1/CD158a Products

Antibodies
Lysates
KIR2DL1/CD158a 293T Cell Tran ...
KIR2DL1/CD158a 293T Cell Transient...
H00003802-T02
Species: Hu
Applications: WB
Proteins
Recombinant Human KIR2DL1/CD1 ...
Recombinant Human KIR2DL1/CD158a F...
1844-KR
Species: Hu
Applications: Bioactivity
Formulation Catalog # Availability Price  

Description

KIRDL2, also known as CD158a, belongs to the killer-cell immunoglobulin-like receptor (KIR) gene family expressed by natural killer (NK) cells and functions in inhibitory signaling (1,2). The KIR genes consisting of 15 gene loci and two pseudogenes are located on chromosome 19 and segregated into halptype A or B depending on gene composition (1). Human KIR2DL1 belongs to haplotype A and is synthesized as a protein of 348 amino acids (aa) in length with a theoretical molecular weight (MW) of 38.5 kDa (3). The KIR2DL1 protein consists of two extracellular immunoglobulin (Ig)-like C2 domains, a transmembrane domain, and a long cytoplasmic tail containing an immunoreceptor tyrosine-based inhibitory motif (ITIM) (1,3). KIR2DL1 binds human leukocyte antigen (HLA) alleles with the C2 supratype, resulting in an inhibitory immune response and suppression of NK cell activity to target cells (1,2). KIR2DL1 has been shown to be a potential clinical biomarker for diseases related to suppressed NK cell function (4). An increase in inhibitory receptors such as KIR2DL1/CD158a is observed in certain pathologies like endometriosis and multiple myeloma (4,5). Therapeutic inhibition of KIR2DL1 may be a potential treatment option for endometriosis patients (5). Additionally, blocking of KIR2DL1 combined with rituximab, and anti-CD20 monoclonal antibody, has shown increased NK cell cytotoxicity than just the antibody itself (5).

References

1. Debska-Zielkowska J, Moszkowska G, Zielinski M, et al. KIR Receptors as Key Regulators of NK Cells Activity in Health and Disease. Cells. 2021;10(7):1777. Published 2021 Jul 14. https://doi.org/10.3390/cells10071777

2. Goodson-Gregg FJ, Krepel SA, Anderson SK. Tuning of human NK cells by endogenous HLA-C expression. Immunogenetics. 2020;72(4):205-215. https://doi.org/10.1007/s00251-020-01161-x

3. Uniprotkb (P43626)

4. Konjevic G, Jurisic V, Jovic V, et al. Investigation of NK cell function and their modulation in different malignancies. Immunol Res. 2012;52(1-2):139-156. https://doi.org/10.1007/s12026-012-8285-7

5. Hoogstad-van Evert J, Paap R, Nap A, van der Molen R. The Promises of Natural Killer Cell Therapy in Endometriosis. Int J Mol Sci. 2022;23(10):5539. Published 2022 May 16. https://doi.org/10.3390/ijms23105539

Bioinformatics

Entrez Human
Uniprot Human
Human
Human
Product By Gene ID 3802
Alternate Names
  • CD158 antigen-like family member A
  • CD158a antigen
  • CD158Ankat1
  • cl-42
  • killer cell immunoglobulin-like receptor 2DL1
  • killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
  • killer Ig receptor
  • killer inhibitory receptor 2-2-1
  • KIR221
  • MHC class I NK cell receptor
  • Natural killer-associated transcript 1
  • NKAT
  • NKAT-1
  • NKAT1KIR-K64
  • p58 killer cell inhibitory receptor KIR-K64
  • p58 natural killer cell receptor clones CL-42/47.11
  • p58 NK cell inhibitory receptor NKR-K6,47.11
  • p58 NK receptor CL-42/47.11
  • p58.1 MHC class-I-specific NK receptor
  • p58.1